Active Ingredient: Antazoline
Paroxysmal arrhythmias of supraventricular origin, including tachyarrhythmia in atrial fibrillation, unresponsive to standard antiarrhythmic treatment.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Intravenous, in total between 100 milligrams antazoline and 300 milligrams antazoline, over the duration of 3 to 10 minutes.
Administer intravenously under strict control of blood pressure and heart rate (ECG), at a dose of 100 mg to 300 mg in 3-10 minutes. Injections should be stopped once obtained return of sinus rhythm.
Higher doses should be used in the intensive care unit.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
